Linked Life Data

17960855

Source:http://linkedlifedata.com/resource/pubmed/id/17960855

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-12-24
pubmed:abstractText
The prevalence of elevated liver enzymes has not been described in patients with atrial fibrillation (AF) who may be more likely to develop these abnormalities due to comorbidities and medications. As signals of liver injury lead to termination of drug development programs, an attempt to better define the background prevalence would aid in interpreting these elevations in the setting of exposure to a new drug. The aim of this study was to estimate the prevalence and incidence of alanine aminotransferase (ALT) elevations in a cohort with AF.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1053-8569
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
43-51
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population.
pubmed:affiliation
Division of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. george.makar@uphs.upenn.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't